Bliley Brown & Williamson
Confidential Report Outlining Significant Y1 Events Prepared in Connection with Product Litigation by B&W Outside Counsel and Forwarded to B&W Management
Fields
- Type
- REPORT
- Author
- B&W Outside Counsel
Document Images
PRIVILEGED AND CONFIDENTIAL
ATTORNEY WORK PRODUCT
CHRONOLOGY OF SIGNIFICANT Y1 EVENTS
DATE
Mid-1970's
1977
1978
1981
1981-1982
Aug. 8, 1983
Feb. 21,1991
Sept. 17, 1991
Sept. 16, 1992
Feb. 1993
Feb. 28, 1994
EVENT
Dr. James F. Chaplin, Director of the USDA Research Laboratory at
Oxford, NC, conducts plant breeding research to develop a high nicotine
tobacco variety that could be useful in the production of low tar cigarettes.
After six years of research, Dr. Chaplin crosses Nicotiana tabucum with
Nicotiana rustica to produce high nicotine tobacco variety that was the
precursor to YI tobacco.
Dr. Chaplin discusses idea of using high nicotine tobacco to produce low
tar cigarette at the International Tobacco Scientific Symposium in Sofia,
Bulgaria.
Mr. Hugh Hardison, a Vice President of Export Leaf Tobacco Company, a
B&W affiliate, hears Dr. Chaplin describe his N. tabucum/N, rustica cross
at a tobacco industry conference. Mr. Hardison requests and obtains from
Dr. Chaplin seeds from the five lines Dr. Chaplin produced from this cross.
Mr. Hardison grows plants from all five lines obtained from Dr. Chaplin
and selects two lines for further experimentation. Mr. Hardison designates
these two lines as Y I and Y2.
B&W and DNA Plant Technology Corporation (DNAP) initiate agreement
for the performance of certain tobacco research including the production of
tobacco lines with elevated nicotine content.
B&W files application for U.S. plant variety protection certificate.
B&W files U.S. patent application for YI tobacco.
B&W files Brazilian patent application for Y1 tobacco.
B&W begins to sell cigarettes containing expanded Y1 tobacco in the
blend.
Patent counsel for B&W files appeal of denial of U.S. patent for YI.
March 14, 1994
March 16, 1994
March 29, 1994
May 1994
June 21, 1994
June 23, 1994
PRIVILEGED AND CONFIDENTIAL
ATTORNEY WORK PRODUCT
B&W withdraws application for U.S. plant variety protection certificate.
B&W abandons U.S. Yl patent application.
B&W withdraws Brazilian ¥1 patent application.
B&W decides to stop selling cigarettes containing ¥1 tobacco in the blend.
Dr. David Kessler, FDA Commissioner, testifies before the House
Subcommittee on Health and the Environment regarding ¥1.
Mr. Thomas E. Sandefur, Chairman and CEO of B&W, testifies before the
House Subcommittee on Health and the Environment regarding Y1.
WDC-21185-1
June 26. 1995-15:15:29
